Modeling and prediction of cocrystal phase diagrams.

In this paper, a new approach to model cocrystal phase diagrams is presented. Starting from an initial set of data, the phase diagram is obtained from discontinuous isoperibolic thermal analysis (DITA) and basic thermodynamic data (enthalpies and solubilities). The solubility product constant may then be determined. Since this constant is solvent independent, extrapolation to other solvents is possible. Application of this technique to an active pharmaceutical ingredient and glutaric acid demonstrates good agreement between calculated and experimental data.

[1]  William Jones,et al.  Pharmaceutical Cocrystallization: Engineering a Remedy for Caffeine Hydration , 2005 .

[2]  Studies on the molecular compounds of organic medicinals. II. Application of the solubility product principle and consideration by the phase rule to the solubility phenomena of the molecular compound of sulfanilamide and sulfathiazole. , 1966, Chemical & pharmaceutical bulletin.

[3]  Narayan Variankaval,et al.  Preparation and Solid-State Characterization of Nonstoichiometric Cocrystals of a Phosphodiesterase-IV Inhibitor and l-Tartaric Acid , 2006 .

[4]  J. McMahon,et al.  Crystal engineering of the composition of pharmaceutical phases. , 2003, Chemical communications.

[5]  Aeri Park,et al.  The salt-cocrystal continuum: the influence of crystal structure on ionization state. , 2007, Molecular pharmaceutics.

[6]  Sarah J. Nehm,et al.  Phase solubility diagrams of cocrystals are explained by solubility product and solution complexation , 2006 .

[7]  Christer B. Aakeröy,et al.  Building co-crystals with molecular sense and supramolecular sensibility , 2005 .

[8]  Orn Almarsson,et al.  Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines? , 2003, Chemical communications.

[9]  Aeri Park,et al.  Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API , 2006, Pharmaceutical Research.

[10]  C. Aakeröy,et al.  2-Acetaminopyridine: A Highly Effective Cocrystallizing Agent , 2006 .

[11]  G. Coquerel,et al.  Diastereomeric resolution rationalized by phase diagrams under the actual conditions of the experimental process , 2004 .

[12]  K. Harris,et al.  Co-crystalline hydrogen bonded solids based on the alcohol–carboxylic acid–alcohol supramolecular motif , 2004 .

[13]  Christer B Aakeröy,et al.  Cocrystal or salt: does it really matter? , 2007, Molecular pharmaceutics.

[14]  J. McMahon,et al.  Crystal engineering of pharmaceutical co-crystals from polymorphic active pharmaceutical ingredients. , 2005, Chemical communications.

[15]  Geoff G. Z. Zhang,et al.  Efficient co-crystal screening using solution-mediated phase transformation. , 2007, Journal of pharmaceutical sciences.

[16]  Sarah J. Nehm,et al.  Reaction crystallization of pharmaceutical molecular complexes. , 2006, Molecular pharmaceutics.

[17]  Sekhar Surapaneni,et al.  The co-crystal approach to improve the exposure of a water-insoluble compound: AMG 517 sorbic acid co-crystal characterization and pharmacokinetics. , 2008, Journal of pharmaceutical sciences.

[18]  R. Tan,et al.  Effect of Water Activity on the Transformation between Hydrate and Anhydrate of Carbamazepine , 2008 .

[19]  M. Zaworotko,et al.  From molecules to crystal engineering: supramolecular isomerism and polymorphism in network solids. , 2001, Chemical reviews.

[20]  Orn Almarsson,et al.  Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids. , 2003, Journal of the American Chemical Society.

[21]  Dario Braga,et al.  Making crystals from crystals: a green route to crystal engineering and polymorphism. , 2005, Chemical communications.

[22]  W. Jones,et al.  Mechanochemistry and co-crystal formation: effect of solvent on reaction kinetics. , 2002, Chemical communications.

[23]  C. Kennard,et al.  Molecular Cocrystals of Carboxylic Acids. XXV The Utility of Urea in Structure Making with Carboxylic Acids and the Crystal Structures of a Set of Six Adducts with Aromatic Acids , 1997 .

[24]  W. Motherwell,et al.  Physical stability enhancement of theophylline via cocrystallization. , 2006, International journal of pharmaceutics.

[25]  R. Davey,et al.  Making Co-crystals-The utility of ternary phase diagrams , 2007 .

[26]  P York,et al.  Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. , 2007, Advanced drug delivery reviews.

[27]  Jean Jacques,et al.  Enantiomers, Racemates, and Resolutions , 1981 .